This large randomized, double-blind, multicenter trial will test whether precision neuroimaging-guided continuous theta-burst stimulation targeting the left supplementary motor area improves motor symptoms in 290 Parkinson's patients versus sham, with primary outcome MDS-UPDRS III at day 8 and…
A positive result would provide high-quality clinical evidence for a noninvasive, reproducible neuromodulation therapy as an adjunctive symptomatic treatment for PD motor deficits and support broader translational development of precision rTMS protocols.